
Beyond analysts' top-and-bottom-line estimates for Lineage, Inc. (LINE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
| Revenue (TTM) | $5.37B |
| Gross Profit (TTM) | $1.72B |
| EBITDA | $1.16B |
| Operating Margin | 3.67% |
| Return on Equity | -2.04% |
| Return on Assets | 0.75% |
| Revenue/Share (TTM) | $23.66 |
| Book Value | $34.66 |
| Price-to-Book | 1.14 |
| Price-to-Sales (TTM) | 1.83 |
| EV/Revenue | 3.153 |
| EV/EBITDA | 15.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $227.67M |
| Float | $57.60M |
| % Insiders | 68.46% |
| % Institutions | 34.15% |
Volatility is currently expanding

Beyond analysts' top-and-bottom-line estimates for Lineage, Inc. (LINE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.

The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exelixis rounded out our top contributors.

NOVI, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the third quarter of 2026 on Monday, November 9, 2026, after market close. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Tuesday, November 10, 2026.

JACKSONVILLE, Fla. and NOVI, Mich.

NOVI, Mich., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) (“Lineage” or the “Company”), the world's largest global temperature-controlled warehouse REIT, today announced the appointment of Paul Beiboer to its Board of Directors (“Board”). Beiboer's appointment to the Board is effective September 23, 2026, and he will also serve as a member of the Board's Talent and Compensation Committee.

NOVI, Mich., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced that its Board of Directors has declared a cash dividend of $0.5325 per share for the third quarter of 2026. The dividend will be paid on October 21, 2026, to shareholders of record of the Company's common stock as of the close of business on September 30, 2026.

Plus, Houthi militants expand control near a strategic Red Sea chokepoint, and the Amazon plane crash is putting a spotlight on freight carrier 21 Air.

The world's largest cold-storage operator claims negligence caused a massive blaze and is seeking over $1 billion in damages.

LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) today filed a civil lawsuit in Los Angeles Superior Court against Altus Power, Inc., a commercial solar operator, and its contractor Pearce Services LLC, a subsidiary of CBRE Group, alleging that their negligence caused the June 17, 2026, fire that destroyed Lineage's 500,000 square-foot cold storage facility in the Boyle Heights neighborhood in Los Angeles.

Lineage (LINE) remains a Buy, with valuation offering a strong margin of safety despite near-term macro headwinds and operational volatility. Q2 results beat expectations; AFFO per share fell 6.2% to $0.76, but guidance was raised to $2.80–$3.05 for full year. LINE's technological and operational advantages drive competitiveness, yet higher leverage (net debt/EBITDA at 6.0x) and industry risks require close monitoring.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LINE and any ticker you trade — then tracks every position and per-strategy win rate.